As we enter historically low interest rate environments, there’s never been a better time to achieve consistent, high-yield financial returns while positively impacting the future of global healthcare. The life sciences and biotechnology sector ranks among the most attractive of all fast-growing industries of the 21st century with an estimated annual growth rate in double digits.
Mega trends such as population growth, increasing life expectancy, rapid urbanisation and sedentary lifestyles are powerful growth drivers. Tremendous increases in healthcare costs globally only amplifies the need for more efficient patient treatment mechanisms, and thus an urgency for robust pipelines in bioscience innovation for the development of new life-changing medicines.
At EBI, we invest across the entire bioscience sector – from chemical, biologic, genetic pharmaceutical interventions, to advanced point of care diagnostics, medicine nanorobotics, all at the forefront of medical research. With EBI Fixed Income, investors can now take advantage of our global portfolio of diversified investments across the biotechnology sector carefully selected and validated by our in-house scientific and investment banking experts.